Efficient synthesis and characterization of novel indolizines: exploration of in vitro COX-2 inhibitory activity and molecular modelling studies

A series of novel indolizine scaffolds incorporating a cyano group at position 7 as potential cyclooxygenase (COX)-2 inhibitors has been synthesized and characterized by FT-IR, NMR, LC-MS, and elemental analysis. A molecular modelling study was carried out to explore the COX-2 binding properties of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:New journal of chemistry 2018, Vol.42 (7), p.4893-4901
Hauptverfasser: Chandrashekharappa, Sandeep, Venugopala, Katharigatta N., Tratrat, Christophe, Mahomoodally, Fawzi M., Aldhubiab, Bandar E., Haroun, Michelyne, Venugopala, Rashmi, Mohan, Mahendra K., Kulkarni, Rashmi S., Attimarad, Mahesh V., Harsha, Sree, Odhav, Bharti
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A series of novel indolizine scaffolds incorporating a cyano group at position 7 as potential cyclooxygenase (COX)-2 inhibitors has been synthesized and characterized by FT-IR, NMR, LC-MS, and elemental analysis. A molecular modelling study was carried out to explore the COX-2 binding properties of the synthesized compounds, in an endeavour to provide additional insights into the inhibitory potential to treat and/or manage inflammation and pain. All compounds demonstrated comparable docking scores with that of indomethacin, a potent nonsteroidal anti-inflammatory drug. Additional empirical scoring functions were also investigated to estimate the best ligand orientation into the binding site. Halogen atoms at the para position of the benzoyl ring at the third position of the indolizine nucleus showed promising COX-2 inhibitory activity. The observed promising activity was favoured by the ethyl moiety at the second position of the indolizine nucleus. These findings will provide insights into structural requirements for designing novel indolizine scaffolds as potent COX-2 inhibitors.
ISSN:1144-0546
1369-9261
DOI:10.1039/C7NJ05010K